Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferoxamine for spontaneous intracerebral hemorrhage
ChiCTR-IPR-15007394Phase 4Not yet recruiting
- Sponsor
- Huashan Hospital
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of deferoxamine in intracerebral hemorrhage (ICH) (2 arms), sponsored by Huashan Hospital. Primary endpoint: Decrease in hemorrhage volume. Planned start Jan 2016; status: not yet recruiting.
02
Drugs
deferoxamine
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on ChiCTR-IPR-15007394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007394.